- Previous Close
119.80 - Open
119.60 - Bid 119.20 x --
- Ask 119.20 x --
- Day's Range
117.60 - 119.60 - 52 Week Range
117.60 - 156.80 - Volume
168,297 - Avg. Volume
219,564 - Market Cap (intraday)
15.418B - Beta (5Y Monthly) 0.17
- PE Ratio (TTM)
18.47 - EPS (TTM)
6.42 - Earnings Date --
- Forward Dividend & Yield 5.00 (4.17%)
- Ex-Dividend Date Aug 12, 2024
- 1y Target Est
142.44
Nahdi Medical Company operates as a pharmaceutical retailer in the Kingdom of Saudi Arabia and the United Arab Emirates. The company offers pharmaceutical and health products, such as health and wellness, mom and baby, beauty, and everyday essential products through retail and online stores. It also provides healthcare services, including polyclinics, express clinics, telemedicine services, and home healthcare, as well as operates an E-Pharmacist platform. In addition, the company engages in the wholesale and retail of medical devices and equipment, cosmetics, pharmaceutical products, and special and healthy foods; pharmaceuticals warehouse activities; administrative and support services, human health and social work, public administration, and compulsory defense and social security activities; provision of cleaning services for general buildings; investing in, establishing, and managing health and commercial projects; and consultations, technical support, projects management, and online trading businesses. The company was incorporated in 1986 and is headquartered in Jeddah, the Kingdom of Saudi Arabia.
www.nahdi.sa5,169
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 4164.SR
View MorePerformance Overview: 4164.SR
Trailing total returns as of 11/21/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4164.SR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4164.SR
View MoreValuation Measures
Market Cap
15.57B
Enterprise Value
16.31B
Trailing P/E
18.66
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.68
Price/Book (mrq)
6.46
Enterprise Value/Revenue
1.75
Enterprise Value/EBITDA
10.25
Financial Highlights
Profitability and Income Statement
Profit Margin
8.96%
Return on Assets (ttm)
9.80%
Return on Equity (ttm)
35.58%
Revenue (ttm)
9.3B
Net Income Avi to Common (ttm)
833.39M
Diluted EPS (ttm)
6.42
Balance Sheet and Cash Flow
Total Cash (mrq)
747.65M
Total Debt/Equity (mrq)
61.61%
Levered Free Cash Flow (ttm)
560.55M